nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Chest pain—Bleomycin—testicular cancer	0.00209	0.00209	CcSEcCtD
Nafarelin—Myalgia—Bleomycin—testicular cancer	0.00209	0.00209	CcSEcCtD
Nafarelin—Myocardial infarction—Etoposide—testicular cancer	0.00208	0.00208	CcSEcCtD
Nafarelin—Cystitis noninfective—Epirubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Nafarelin—Decreased appetite—Vinblastine—testicular cancer	0.00207	0.00207	CcSEcCtD
Nafarelin—Urticaria—Chlorambucil—testicular cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Cystitis—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—testicular cancer	0.00204	0.00204	CcSEcCtD
Nafarelin—Constipation—Vinblastine—testicular cancer	0.00203	0.00203	CcSEcCtD
Nafarelin—Oedema—Bleomycin—testicular cancer	0.00201	0.00201	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—testicular cancer	0.00195	0.00195	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Anorexia—Bleomycin—testicular cancer	0.00191	0.00191	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Nafarelin—Vertigo—Ifosfamide—testicular cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—testicular cancer	0.00187	0.00187	CcSEcCtD
Nafarelin—Asthenia—Chlorambucil—testicular cancer	0.00186	0.00186	CcSEcCtD
Nafarelin—Palpitations—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Nafarelin—Alopecia—Cisplatin—testicular cancer	0.00184	0.00184	CcSEcCtD
Nafarelin—Pruritus—Chlorambucil—testicular cancer	0.00184	0.00184	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00183	0.00183	CcSEcCtD
Nafarelin—Convulsion—Ifosfamide—testicular cancer	0.00182	0.00182	CcSEcCtD
Nafarelin—Malnutrition—Cisplatin—testicular cancer	0.00181	0.00181	CcSEcCtD
Nafarelin—Paraesthesia—Bleomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Dyspnoea—Bleomycin—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Arthralgia—Ifosfamide—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Chest pain—Ifosfamide—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Myalgia—Ifosfamide—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—testicular cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Nafarelin—Diarrhoea—Chlorambucil—testicular cancer	0.00178	0.00178	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Nafarelin—Decreased appetite—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Nafarelin—Oedema—Ifosfamide—testicular cancer	0.00172	0.00172	CcSEcCtD
Nafarelin—Eye pain—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Asthenia—Vinblastine—testicular cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Alopecia—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Hyperhidrosis—Ifosfamide—testicular cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Vomiting—Chlorambucil—testicular cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Anorexia—Ifosfamide—testicular cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—testicular cancer	0.00163	0.00163	CcSEcCtD
Nafarelin—Diarrhoea—Vinblastine—testicular cancer	0.00163	0.00163	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Nafarelin—Urticaria—Bleomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Dizziness—Vinblastine—testicular cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Convulsion—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00156	0.00156	CcSEcCtD
Nafarelin—Myalgia—Cisplatin—testicular cancer	0.00154	0.00154	CcSEcCtD
Nafarelin—Nausea—Chlorambucil—testicular cancer	0.00154	0.00154	CcSEcCtD
Nafarelin—Paraesthesia—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Nafarelin—Dyspnoea—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Vomiting—Vinblastine—testicular cancer	0.00151	0.00151	CcSEcCtD
Nafarelin—Vertigo—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Decreased appetite—Ifosfamide—testicular cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Headache—Vinblastine—testicular cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Oedema—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Nafarelin—Constipation—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Nafarelin—Asthenia—Bleomycin—testicular cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Convulsion—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Hyperhidrosis—Cisplatin—testicular cancer	0.00143	0.00143	CcSEcCtD
Nafarelin—Pruritus—Bleomycin—testicular cancer	0.00142	0.00142	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Nafarelin—Chest pain—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Nausea—Vinblastine—testicular cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Anorexia—Cisplatin—testicular cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Urticaria—Ifosfamide—testicular cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00135	0.00135	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—testicular cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Nafarelin—Paraesthesia—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Nafarelin—Dyspnoea—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Nafarelin—Anorexia—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Nafarelin—Decreased appetite—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Nafarelin—Vomiting—Bleomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Nafarelin—Depression—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Rash—Bleomycin—testicular cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Dermatitis—Bleomycin—testicular cancer	0.00126	0.00126	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Nafarelin—Asthenia—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Nafarelin—Pruritus—Ifosfamide—testicular cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Nafarelin—Nausea—Bleomycin—testicular cancer	0.00119	0.00119	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—testicular cancer	0.00119	0.00119	CcSEcCtD
Nafarelin—Rash—Dactinomycin—testicular cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Diarrhoea—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Constipation—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Dizziness—Ifosfamide—testicular cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—testicular cancer	0.00111	0.00111	CcSEcCtD
Nafarelin—Vomiting—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Rash—Ifosfamide—testicular cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Dermatitis—Ifosfamide—testicular cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Urticaria—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Nafarelin—Asthenia—Cisplatin—testicular cancer	0.00106	0.00106	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Nafarelin—Nausea—Ifosfamide—testicular cancer	0.00102	0.00102	CcSEcCtD
Nafarelin—Diarrhoea—Cisplatin—testicular cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—testicular cancer	0.000995	0.000995	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—testicular cancer	0.000992	0.000992	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—testicular cancer	0.000974	0.000974	CcSEcCtD
Nafarelin—Asthenia—Etoposide—testicular cancer	0.000972	0.000972	CcSEcCtD
Nafarelin—Pruritus—Etoposide—testicular cancer	0.000959	0.000959	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Nafarelin—Vomiting—Cisplatin—testicular cancer	0.000941	0.000941	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—testicular cancer	0.000937	0.000937	CcSEcCtD
Nafarelin—Rash—Cisplatin—testicular cancer	0.000933	0.000933	CcSEcCtD
Nafarelin—Dermatitis—Cisplatin—testicular cancer	0.000932	0.000932	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—testicular cancer	0.000931	0.000931	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—testicular cancer	0.000927	0.000927	CcSEcCtD
Nafarelin—Tension—Epirubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—testicular cancer	0.000904	0.000904	CcSEcCtD
Nafarelin—Dizziness—Etoposide—testicular cancer	0.000896	0.000896	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—testicular cancer	0.000894	0.000894	CcSEcCtD
Nafarelin—Nausea—Cisplatin—testicular cancer	0.000879	0.000879	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—testicular cancer	0.000874	0.000874	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—testicular cancer	0.000867	0.000867	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—testicular cancer	0.000862	0.000862	CcSEcCtD
Nafarelin—Vomiting—Etoposide—testicular cancer	0.000862	0.000862	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Nafarelin—Rash—Etoposide—testicular cancer	0.000855	0.000855	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—testicular cancer	0.000854	0.000854	CcSEcCtD
Nafarelin—Headache—Etoposide—testicular cancer	0.000849	0.000849	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Nafarelin—Tension—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—testicular cancer	0.000837	0.000837	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—testicular cancer	0.000823	0.000823	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Nafarelin—Nausea—Etoposide—testicular cancer	0.000805	0.000805	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—testicular cancer	0.000785	0.000785	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—testicular cancer	0.000774	0.000774	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—testicular cancer	0.000774	0.000774	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Nafarelin—Oedema—Epirubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Nafarelin—Shock—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—testicular cancer	0.000746	0.000746	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00074	0.00074	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—testicular cancer	0.000734	0.000734	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—testicular cancer	0.000729	0.000729	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—testicular cancer	0.000724	0.000724	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—testicular cancer	0.000724	0.000724	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—testicular cancer	0.000706	0.000706	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Nafarelin—Shock—Doxorubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Nafarelin—Constipation—Epirubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—testicular cancer	0.000645	0.000645	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—testicular cancer	0.000582	0.000582	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—testicular cancer	0.000574	0.000574	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—testicular cancer	0.000555	0.000555	CcSEcCtD
Nafarelin—Asthenia—Epirubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—testicular cancer	0.000537	0.000537	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—testicular cancer	0.000516	0.000516	CcSEcCtD
Nafarelin—Rash—Methotrexate—testicular cancer	0.000512	0.000512	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—testicular cancer	0.000511	0.000511	CcSEcCtD
Nafarelin—Headache—Methotrexate—testicular cancer	0.000509	0.000509	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—testicular cancer	0.000497	0.000497	CcSEcCtD
Nafarelin—Vomiting—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Nafarelin—Nausea—Methotrexate—testicular cancer	0.000482	0.000482	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
Nafarelin—Rash—Epirubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Nafarelin—Headache—Epirubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Nafarelin—Nausea—Epirubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Nafarelin—Rash—Doxorubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Nafarelin—Headache—Doxorubicin—testicular cancer	0.00044	0.00044	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
